Browsing Tag
Evolocumab
1 post
FDA Okays Evolocumab Add-On for FH in Children Aged 10 and Up
The US Food and Drug Administration (FDA) has approved evolocumab (Repatha, Amgen), a PCSK9 inhibitor, for use as add-on treatment to diet alone or with other therapies for children 10 years of age and older with either heterozygous or homozygous familial hypercholesterolemia (FH). Approval was based on randomized trials of evolocumab in both types of…
September 24, 2021